Director Shareholding

Cambridge Antibody Tech Group PLC 07 March 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director Peter Chambre 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) As in 2 above 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Market purchase of 3,541 shares to be held as "Invested Shares" under Executive Incentive Plan 7) Number of shares/amount of stock acquired 3,541 8) Percentage of issued class 0.007% 9) Number of shares/amount of stock disposed None 10) Percentage of issued class None 11) Class of security Ordinary 10 pence shares 12) Price per share £7.06 13) Date of transaction 4 March 2005 14) Date company informed 4 March 2005 15) Total holding following this notification 26,090 16) Total percentage holding of issued class following this notification 0.05% If a director has been granted options by the company please complete the following boxes 17) Date of grant 4 March 2005 18) Period during which or date on which exercisable 4 March 2008 to 3 March 2011 19) Total amount paid (if any) for grant of the option Nil 20) Description of shares or debentures involved: class, number 10,623 Ordinary 10 pence shares 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 10 pence per share subject to Award 22) Total number of shares or debentures over which options held following this notification 343,566 of which: 206,974 are Options under Company Share Option Plan 92,510 are Restricted Share Awards under Executive Incentive Plan 44,082 are Matching Shares under Executive Incentive Plan 23) Any additional information Awards granted under the Executive Incentive Plan are subject to performance conditions 24) Name of contact and telephone number for queries Justin Hoskins: 01223 898589 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Date of Notification 7 March 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director Diane Mellett 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) As in 2 above 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Market purchase of 495 shares to be held as "Invested Shares" under Executive Incentive Plan 7) Number of shares/amount of stock acquired 495 8) Percentage of issued class 0.001% 9) Number of shares/amount of stock disposed None 10) Percentage of issued class None 11) Class of security Ordinary 10 pence shares 12) Price per share £7.06 13) Date of transaction 4 March 2005 14) Date company informed 4 March 2005 15) Total holding following this notification 15,062 16) Total percentage holding of issued class following this notification 0.029% If a director has been granted options by the company please complete the following boxes 17) Date of grant 4 March 2005 18) Period during which or date on which exercisable 4 March 2008 to 3 March 2011 19) Total amount paid (if any) for grant of the option Nil 20) Description of shares or debentures involved: class, number 1,485 Ordinary 10 pence shares 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 10 pence per share subject to Award 22) Total number of shares or debentures over which options held following this notification 112,786 of which: 76,874 are Options under Company Share Option Plan 31,901 are Restricted Share Awards under Executive Incentive Plan 4,011 are Matching Shares under Executive Incentive Plan 23) Any additional information Awards granted under the Executive Incentive Plan are subject to performance conditions 24) Name of contact and telephone number for queries Justin Hoskins: 01223 898589 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Date of Notification 7 March 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director John Aston 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) As in 2 above 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Market purchase of 3,541 shares to be held as "Invested Shares" under Executive Incentive Plan at £7.06 Exercise of options over 25,000 shares at £2.87 and 9,964 shares at £2.42 of which 22,273 shares were sold at £7.00 and 12,691 were retained. 7) Number of shares/amount of stock acquired 38,505 8) Percentage of issued class 0.075% 9) Number of shares/amount of stock disposed 22,273 10) Percentage of issued class 0.043% 11) Class of security Ordinary 10 pence shares 12) Price per share See 6 above 13) Date of transaction 4 March 2005 14) Date company informed 4 March 2005 15) Total holding following this notification 56,421 16) Total percentage holding of issued class following this notification 0.11% If a director has been granted options by the company please complete the following boxes 17) Date of grant 4 March 2005 18) Period during which or date on which exercisable 4 March 2008 to 3 March 2011 19) Total amount paid (if any) for grant of the option Nil 20) Description of shares or debentures involved: class, number 10,623 Ordinary 10 pence shares 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 10 pence per share subject to Award 22) Total number of shares or debentures over which options held following this notification 125,733 of which: 51,087 are Options under Company Share Option Plan 57,765 are Restricted Share Awards under Executive Incentive Plan 16,881 are Matching Shares under Executive Incentive Plan 23) Any additional information Awards granted under the Executive Incentive Plan are subject to performance conditions 24) Name of contact and telephone number for queries Justin Hoskins: 01223 898589 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Date of Notification 7 March 2005 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings